Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.14 Billion CNY | 14.45% |
| 2022 | 3.61 Billion CNY | 34.31% |
| 2021 | 2.69 Billion CNY | 39.61% |
| 2020 | 1.92 Billion CNY | 41.82% |
| 2019 | 1.36 Billion CNY | -9.34% |
| 2018 | 1.5 Billion CNY | 136363.64% |
| 2017 | 1.1 Million CNY | 0.0% |
| 2016 | 1.1 Million CNY | -99.83% |
| 2015 | 651.1 Million CNY | -22.75% |
| 2014 | 842.82 Million CNY | -19.07% |
| 2013 | 1.04 Billion CNY | 93.83% |
| 2012 | 537.26 Million CNY | 112.42% |
| 2011 | 252.92 Million CNY | -26.62% |
| 2010 | 344.65 Million CNY | 11.28% |
| 2009 | 309.71 Million CNY | -50.98% |
| 2008 | 631.81 Million CNY | 28.65% |
| 2007 | 491.11 Million CNY | -28.97% |
| 2006 | 691.38 Million CNY | 16.24% |
| 2005 | 594.79 Million CNY | 10.47% |
| 2004 | 538.4 Million CNY | 4.04% |
| 2003 | 517.5 Million CNY | 103.21% |
| 2002 | 254.66 Million CNY | -15.72% |
| 2001 | 302.17 Million CNY | 34.71% |
| 2000 | 224.31 Million CNY | 15.23% |
| 1999 | 194.66 Million CNY | -11.24% |
| 1998 | 219.32 Million CNY | 14.34% |
| 1997 | 191.81 Million CNY | -38.69% |
| 1996 | 312.88 Million CNY | 55.57% |
| 1995 | 201.11 Million CNY | 83.06% |
| 1994 | 109.86 Million CNY | 4.79% |
| 1993 | 104.84 Million CNY | -54.0% |
| 1992 | 227.93 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.56 Billion CNY | -13.94% |
| 2024 Q3 | 2.46 Billion CNY | -38.86% |
| 2024 Q2 | 4.03 Billion CNY | 13.31% |
| 2023 Q2 | 4.25 Billion CNY | 5.13% |
| 2023 FY | 4.14 Billion CNY | 14.45% |
| 2023 Q4 | 4.14 Billion CNY | 3.24% |
| 2023 Q1 | 4.04 Billion CNY | 11.91% |
| 2023 Q3 | 4.01 Billion CNY | -5.78% |
| 2022 Q2 | 3.29 Billion CNY | 7.77% |
| 2022 Q3 | 3.5 Billion CNY | 6.61% |
| 2022 Q4 | 3.61 Billion CNY | 3.12% |
| 2022 FY | 3.61 Billion CNY | 34.31% |
| 2022 Q1 | 3.05 Billion CNY | 13.37% |
| 2021 Q4 | 2.69 Billion CNY | 7.4% |
| 2021 Q3 | 2.5 Billion CNY | 3.77% |
| 2021 FY | 2.69 Billion CNY | 39.61% |
| 2021 Q2 | 2.41 Billion CNY | 18.85% |
| 2021 Q1 | 2.03 Billion CNY | 5.4% |
| 2020 Q2 | 270.88 Million CNY | -1.7% |
| 2020 Q1 | 275.57 Million CNY | -79.75% |
| 2020 FY | 1.92 Billion CNY | 41.82% |
| 2020 Q3 | 1.47 Billion CNY | 442.99% |
| 2020 Q4 | 1.92 Billion CNY | 31.21% |
| 2019 FY | 1.36 Billion CNY | -9.34% |
| 2019 Q4 | 1.36 Billion CNY | 340110.16% |
| 2019 Q3 | 400 Thousand CNY | 0.0% |
| 2019 Q2 | 400 Thousand CNY | -63.64% |
| 2019 Q1 | 1.1 Million CNY | -99.93% |
| 2018 Q3 | 1.1 Million CNY | -99.6% |
| 2018 Q4 | 1.5 Billion CNY | 136363.64% |
| 2018 FY | 1.5 Billion CNY | 136363.64% |
| 2018 Q1 | 151.1 Million CNY | 13636.36% |
| 2018 Q2 | 273.18 Million CNY | 80.8% |
| 2017 Q2 | 1.1 Million CNY | 0.0% |
| 2017 Q4 | 1.1 Million CNY | 0.0% |
| 2017 Q3 | 1.1 Million CNY | 0.0% |
| 2017 Q1 | 1.1 Million CNY | 0.0% |
| 2017 FY | 1.1 Million CNY | 0.0% |
| 2016 FY | 1.1 Million CNY | -99.83% |
| 2016 Q4 | 1.1 Million CNY | -99.69% |
| 2016 Q3 | 351.1 Million CNY | -59.23% |
| 2016 Q2 | 861.1 Million CNY | 32.25% |
| 2016 Q1 | 651.1 Million CNY | 0.0% |
| 2015 Q3 | 851.1 Million CNY | -25.83% |
| 2015 FY | 651.1 Million CNY | -22.75% |
| 2015 Q1 | 778.41 Million CNY | -7.64% |
| 2015 Q2 | 1.14 Billion CNY | 47.42% |
| 2015 Q4 | 651.1 Million CNY | -23.5% |
| 2014 Q3 | 1.22 Billion CNY | -0.64% |
| 2014 Q1 | 1.39 Billion CNY | 33.52% |
| 2014 Q2 | 1.23 Billion CNY | -11.24% |
| 2014 FY | 842.82 Million CNY | -19.07% |
| 2014 Q4 | 842.82 Million CNY | -31.27% |
| 2013 Q2 | 1.04 Billion CNY | 61.3% |
| 2013 FY | 1.04 Billion CNY | 93.83% |
| 2013 Q4 | 1.04 Billion CNY | -15.49% |
| 2013 Q1 | 647.1 Million CNY | 20.44% |
| 2013 Q3 | 1.23 Billion CNY | 18.05% |
| 2012 Q4 | 537.26 Million CNY | -0.48% |
| 2012 FY | 537.26 Million CNY | 112.42% |
| 2012 Q3 | 539.88 Million CNY | 42.98% |
| 2012 Q1 | 252.9 Million CNY | -0.01% |
| 2012 Q2 | 377.6 Million CNY | 49.31% |
| 2011 FY | 252.92 Million CNY | -26.62% |
| 2011 Q4 | 252.92 Million CNY | 20.71% |
| 2011 Q3 | 209.53 Million CNY | -0.06% |
| 2011 Q2 | 209.66 Million CNY | -48.54% |
| 2011 Q1 | 407.43 Million CNY | 18.21% |
| 2010 Q1 | 312.27 Million CNY | 0.83% |
| 2010 Q4 | 344.65 Million CNY | -1.49% |
| 2010 FY | 344.65 Million CNY | 11.28% |
| 2010 Q3 | 349.86 Million CNY | -4.15% |
| 2010 Q2 | 365.02 Million CNY | 16.89% |
| 2009 Q4 | 309.71 Million CNY | -19.68% |
| 2009 Q1 | 391.8 Million CNY | -37.99% |
| 2009 Q2 | 353.14 Million CNY | -9.87% |
| 2009 Q3 | 385.58 Million CNY | 9.18% |
| 2009 FY | 309.71 Million CNY | -50.98% |
| 2008 Q1 | 552.98 Million CNY | 12.6% |
| 2008 Q2 | 702.3 Million CNY | 27.0% |
| 2008 FY | 631.81 Million CNY | 28.65% |
| 2008 Q3 | 671.23 Million CNY | -4.42% |
| 2008 Q4 | 631.81 Million CNY | -5.87% |
| 2007 Q2 | 646.31 Million CNY | -0.33% |
| 2007 Q4 | 491.11 Million CNY | -19.21% |
| 2007 FY | 491.11 Million CNY | -28.97% |
| 2007 Q1 | 648.46 Million CNY | -6.21% |
| 2007 Q3 | 607.85 Million CNY | -5.95% |
| 2006 Q3 | 769.23 Million CNY | -11.33% |
| 2006 FY | 691.38 Million CNY | 16.24% |
| 2006 Q4 | 691.38 Million CNY | -10.12% |
| 2006 Q2 | 867.53 Million CNY | 37.56% |
| 2006 Q1 | 630.68 Million CNY | 6.03% |
| 2005 Q4 | 594.79 Million CNY | 1.55% |
| 2005 Q3 | 585.72 Million CNY | 24.32% |
| 2005 Q2 | 471.15 Million CNY | -2.08% |
| 2005 Q1 | 481.15 Million CNY | -10.63% |
| 2005 FY | 594.79 Million CNY | 10.47% |
| 2004 Q4 | 538.4 Million CNY | 10.8% |
| 2004 Q3 | 485.92 Million CNY | -27.57% |
| 2004 Q2 | 670.92 Million CNY | 112.18% |
| 2004 Q1 | 316.2 Million CNY | -38.9% |
| 2004 FY | 538.4 Million CNY | 4.04% |
| 2003 Q2 | 106.47 Million CNY | -53.12% |
| 2003 Q1 | 227.12 Million CNY | -10.82% |
| 2003 FY | 517.5 Million CNY | 103.21% |
| 2003 Q4 | 517.5 Million CNY | 534.19% |
| 2003 Q3 | 81.6 Million CNY | -23.36% |
| 2002 Q3 | 305.22 Million CNY | -23.41% |
| 2002 Q1 | 364.67 Million CNY | 20.68% |
| 2002 FY | 254.66 Million CNY | -15.72% |
| 2002 Q2 | 398.52 Million CNY | 9.28% |
| 2002 Q4 | 254.66 Million CNY | -16.56% |
| 2001 Q4 | 302.17 Million CNY | 0.0% |
| 2001 Q2 | 223.51 Million CNY | 0.0% |
| 2001 FY | 302.17 Million CNY | 34.71% |
| 2000 Q4 | 224.31 Million CNY | 0.0% |
| 2000 Q2 | 178.66 Million CNY | 0.0% |
| 2000 FY | 224.31 Million CNY | 15.23% |
| 1999 FY | 194.66 Million CNY | -11.24% |
| 1999 Q2 | 198.77 Million CNY | 0.0% |
| 1999 Q4 | 194.66 Million CNY | 0.0% |
| 1998 Q4 | 219.32 Million CNY | 0.0% |
| 1998 Q2 | 237.57 Million CNY | 0.0% |
| 1998 FY | 219.32 Million CNY | 14.34% |
| 1997 Q4 | 191.81 Million CNY | 0.0% |
| 1997 FY | 191.81 Million CNY | -38.69% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 312.88 Million CNY | 0.0% |
| 1996 FY | 312.88 Million CNY | 55.57% |
| 1995 Q4 | 201.11 Million CNY | 0.0% |
| 1995 FY | 201.11 Million CNY | 83.06% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 Q4 | 109.86 Million CNY | 0.0% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 FY | 109.86 Million CNY | 4.79% |
| 1993 FY | 104.84 Million CNY | -54.0% |
| 1992 FY | 227.93 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -60714.884% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -21.657% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -3339.493% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -798.471% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -850309.241% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -1928.751% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -1308.565% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -1140.625% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -874.997% |
| SSY Group Limited | 3.37 Billion HKD | -22.744% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -3004.405% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -452.657% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 95.176% |